Skip to main content

Page Title

Ultrasound Blood Brain Barrier Disruption in Neuro-Oncology

Tuesday, October, 13, 2020 10:00 -11:30 am CST

Register for this webinar

Join the Society for Neuro-Oncology (SNO) and the Focused Ultrasound Foundation (FUSF) for an exciting webinar on Tuesday, October 13, 2020, entitled, Ultrasound Blood Brain Barrier Disruption in Neuro-Oncology. Ultrasound mediated blood brain barrier disruption (BBBD) is a rapidly developing approach to enhance small molecule, antibody and cell delivery to brain tumors. Multiple clinical trials are on-going or in development. This webinar will bring together the industry advancing this technology, pharmaceutical and biotech companies, and investigators to update attendees on opportunities and challenges for using ultrasound BBBD to deliver therapeutics to brain tumor patients.


Gelareh Zadeh, MD, PhD
President, Society for Neuro-Oncology      
Suzanne LeBlang, MD
Director of Clinical Operations, Focused Ultrasound Foundation 

10:05-10:20am Overview of the Use of Ultrasound for the Treatment of Glioma
John de Groot, MD
Professor, University of Texas MD Anderson Cancer Center
10:20-10:35am Focused Ultrasound Modulation of the Blood Brain Barrier: Basic Principles and Technological Advances
Kullervo Hynynen, MSc, PhD
Senior Scientist, Sunnybrook Health Sciences Centre
10:35-10:50am Transcranial MR-Guided Focused Ultrasound in Neuro-Oncology: Proof-of-Concept and Experience in Early Phase Human Trials
Nir Lipsman, MD, PhD, FRCSC
Neurosurgeon and Scientist, Sunnybrook Health Sciences Centre
10:50-11:05am Clinical Effectiveness of Targeted and Transient Blood-Brain Barrier Opening via Neuronavigation-Guided Focused Ultrasound for Brain Tumors
Kuo-Chen Wei, MD
Neurosurgeon and Scientist, Chang Gung Memor
ial Hospital
11:05-11:20am  The Use of Skull Implantable Ultrasound for Delivery of Paclitaxel for Glioblastoma 
Adam Sonabend, MD
Assistant Professor of Neurological Surgery, Northwestern University, Feinberg School of Medicine

Register for webinar